-
ABOUT USHebei Guangxiang Pharmaceutical Co., Ltd. is specializing in the production of bulk pharmaceuticals, fine pharmaceuticals, intermediate compounds and biopharmaceutical preparations.
-
News CenterAt the forefront of corporate development, we champion the positive energy of the Four Pharmaceutical Companies: fulfilling our duties conscientiously, stepping up to the plate and taking proactive action, embracing new missions, and conducting effective new publicity. In doing so, we aim to enhance the overall competence of our employees, stimulate their enthusiasm, initiative, and creativity, and provide robust ideological guidance and powerful spiritual strength to drive the enterprise forward.
-
INNOVATIONDevelops fine, series, high-end bulk pharmaceutical intermediates and innovative bulk pharmaceutical intermediates with high added value to build variety competition advantages.
-
-
RECRUITGuangxiang has jointly established engineering laboratories, technology research centers and other high-level innovation platforms with CAS, Zhejiang University, Tianjin University and other universities.
-
CONTACTWith stable production, high-quality and reliable service, the company's products have been sold to more than 80 countries such as the United States, the United Kingdom, Germany and the Netherlands
Leaders of the Provincial Development and Reform Commission Visit Guangxiang Pharmaceutical Group for Research
Category:
TIME：2021-04-12
On March 25, Li Zhi, a second-level inspector with the Hebei Provincial Development and Reform Commission, led a five-member delegation to Guangxiang Pharmaceutical of Shijiazhuang Sihua Pharmaceutical Group, accompanied by relevant officials from Cangzhou City and the Bohai New Area, to conduct a field inspection of the company’s first-quarter economic performance and project construction activities.
Han Shuqin, Chairperson of Guangxiang Pharmaceutical, and Liu Jiaxing, General Manager, provided a detailed briefing to leaders of the Provincial Development and Reform Commission on the development status of Shijiazhuang Sihua Pharmaceutical Group, as well as on the product portfolio and production and operational performance of Guangxiang Pharmaceutical within the group.
The research team commended the enterprise’s performance and operations, while urging it to focus on its annual goals and tasks, implement more effective measures to sustain its current growth momentum, and continue leveraging transformation and development as an opportunity. The team emphasized the need to devote significant effort to project development and investment, seize policy-driven opportunities, accelerate the development of innovation-driven enterprises, cultivate new drivers of economic growth, and promote sustained, stable improvements in the quality of economic performance.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
E-mail: hbgxzy@hebgxzy.com
Address: The west of Jingliu Road, lingang economic nad technological development zone, cangzhou city, Hebei province
Website
Official WeChat
e-Home
